Supply Chain

Ten hospitals and health systems have posted job listings seeking supply chain expertise in the last week:

Sterigenics, an Illinois-based medical supply sterilization plant, has been sued by nearly three dozen people who allege it emitted fumes that have adversely affected their health, according to the Chicago Crusader.

A nationwide shortage of a protein used to help detect tuberculosis via a skin test has prompted Kansas City, Mo. health officials to limit and ration TB skin testing, according to local news station WDAF-TV.

Lauren Davis, product director of medical-surgical solutions at BroadJump, an expense management company, recently spoke with Becker's Hospital Review about the key opportunities for healthcare supply chain teams, emerging technologies in the supply chain space and advice to healthcare leaders on reining…

The FDA has approved Barostim New System, a device to improve symptoms such as fatigue and swelling in patients with advanced heart failure.

Health systems across America are working toward total transportation management, where all freight spend is managed via a single, centralized system and data analytics drive new efficiencies and cost savings.

United States Pharmacopeia (USP) <800> standards highlight the need for healthcare facilities to protect clinicians from exposure to hazardous drugs. Determining how to update operating procedures to comply with the new standards has the potential to overwhelm healthcare facilities. 

United States Pharmacopeia (USP) <800> standards for handling hazardous drugs in healthcare settings is set to go in effect on Dec. 1, 2019. It sets the standards for the safe handling of hazardous drugs from receipt through disposal to ensure…

Pharmaceutical wholesalers Cardinal Health and Kinray agreed to pay $7.5 million to settle allegations that they violated labor laws by denying delivery drivers overtime wages, according to legal news website Law360.

An association of independent nuclear pharmacies in the U.S. has sued Jubilant DraxImage , alleging the supplier engaged in a range of anticompetitive behaviors that boosted prices of drugs and negatively affected patient care, according to STAT.